NCT03211338View on ClinicalTrials.gov

Inflammation and Cell Maturation in Preterm Delivery Placentas - in Vitro and in Vivo Effect of Progesterone

NACompletedINTERVENTIONAL
Enrollment

115

Participants

Timeline

Start Date

July 15, 2017

Primary Completion Date

June 6, 2022

Study Completion Date

June 6, 2022

Conditions
Obstetric Labor, Premature
Interventions
BIOLOGICAL

Culture with progesterone

Progesterone, a steroid hormone will be cultured with placental IMC cells or peripheral blood CD14+ monocyte cells

BIOLOGICAL

Culture without progesterone

Culture of placental IMC cells or peripheral blood CD14+ monocyte cells without progesterone

BIOLOGICAL

Culture with growth factors

Culture of placental IMC cells with growth hormones only and analysis

Trial Locations (1)

38100

Hillel Yaffe Medical Center, Hadera

All Listed Sponsors
lead

Hillel Yaffe Medical Center

OTHER_GOV

NCT03211338 - Inflammation and Cell Maturation in Preterm Delivery Placentas - in Vitro and in Vivo Effect of Progesterone | Biotech Hunter | Biotech Hunter